More recently, research efforts have explored the potential co-activation of the glucose-dependent insulinotropic peptide GIP receptor as a means of enhancing the therapeutic benefits of GLP-1 receptor activation
Some prescription medicines are not compatible with Ozempic, so there may be a need to create a new treatment plan that will be safe and effective for your personal needs
For patients experiencing reduced appetite on tirzepatide, meeting fiber requirements through diet alone may prove challenging
Research design and methods Using the data from the United States Food and Drug Administration Adverse Event Reporting System (FAERS) and Japanese Adverse Drug Event Report (JADER) databases, the differences in adverse events across specific subgroups concerning reporter type, sex, age, dose, indication, report year, onset time, and outcome were investigated using the ROR algorithm and Chi-Square Test/Fishers exact test